• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia

tetano

Editor, Senior Moderator
Nat Commun


. 2022 Aug 9;13(1):4380.
doi: 10.1038/s41467-022-31860-w.
A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia


Cecilia A Sánchez[SUP] 1 [/SUP], Hongying Li[SUP] 1 [/SUP], Kendra L Phelps[SUP] 1 [/SUP], Carlos Zambrana-Torrelio[SUP] 2 [/SUP], Lin-Fa Wang[SUP] 3 [/SUP], Peng Zhou[SUP] 4 [/SUP], Zheng-Li Shi[SUP] 4 [/SUP], Kevin J Olival[SUP] 1 [/SUP], Peter Daszak[SUP] 5 [/SUP]



Affiliations

Abstract

Emerging diseases caused by coronaviruses of likely bat origin (e.g., SARS, MERS, SADS, COVID-19) have disrupted global health and economies for two decades. Evidence suggests that some bat SARS-related coronaviruses (SARSr-CoVs) could infect people directly, and that their spillover is more frequent than previously recognized. Each zoonotic spillover of a novel virus represents an opportunity for evolutionary adaptation and further spread; therefore, quantifying the extent of this spillover may help target prevention programs. We derive current range distributions for known bat SARSr-CoV hosts and quantify their overlap with human populations. We then use probabilistic risk assessment and data on human-bat contact, human viral seroprevalence, and antibody duration to estimate that a median of 66,280 people (95% CI: 65,351-67,131) are infected with SARSr-CoVs annually in Southeast Asia. These data on the geography and scale of spillover can be used to target surveillance and prevention programs for potential future bat-CoV emergence.
 
Back
Top Bottom